Pain Perception in Alzheimer's Disease

Dementia Alzheimer Type Clinical Trial

Official title:

Pain Perception in Alzheimer's Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00192816
• Other study ID #: 2038CTIL
• Status: Recruiting
• Phase: N/A
• First received: September 13, 2005
• Last updated: September 13, 2005
• Start date: June 2005

Study information

• Verified date: September 2005
• Source: Rambam Health Care Campus
• Contact: Maria Nassar, Doctor
• Phone: 0502061707
• Email: mashers[@]netvision.net.il
• Is FDA regulated: No
• Health authority: Israel: Israeli Health Ministry Pharmaceutical Administration
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine response to pain in Alzheimer's disease.We plan to study the effect of diffuse noxious inhibitory controls(counterirritation phenomenon)and the autonomic nervous system reaction(reflected by the heart rate) in Alzheimer's disease. The study's hypothesis is that pain perception and autonomic nervous system reaction are altered in Alzheimer's disease.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 55 Years to 95 Years

Eligibility

Inclusion Criteria:

• Clinical diagnosis of Alzheimer's disease Must be able to understand a simple pain scale

Exclusion Criteria:

Neuropathy Psychotropic drugs use -

Study Design

Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Alzheimer Disease
• Dementia Alzheimer Type

Intervention

Behavioral:
• reaction to pain

Locations

Country	Name	City	State
Israel	Neurocognitive unit,Neurophysiology laborator Rambam Health Care Campus	Haifa

Sponsors (1)

Lead Sponsor	Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel,